July 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The cryopreservation & platelet storage technologies market is growing as it is a promising solution to extend the platelet shelf life, decrease component wastage, and ensure acceptable inventory....
April 21, 2026
The next-generation AI in life sciences market is growing rapidly due to a growing focus on providing high-quality healthcare services in less time. North America’s dominance is attributed to the rising focus on evidence-based healthcare practices, which can be achieved in less time with generative AI....
April 21, 2026
Advantages of ML in drug discovery, including raised efficiency and prediction rates, are accelerating the drug discovery process as growing cases of various diseases are fueling the expansion of the market across the world. Whereas North America dominated the market due to escalating funding and investments in AI and ML-powered drug discovery by p...
April 21, 2026
Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer occurrence as well as growing drug discoveries for chronic diseases. North America led the market d...
April 21, 2026
The drug discovery SaaS platforms market is growing as mainly used in the drug discovery process for virtual screening, data management and analysis, AI-powered drug design, facilitating collaboration, clinical trial optimization, drug repurposing, target identification, and predicting drug efficacy and toxicity. North America is dominated in the m...
April 21, 2026
The computer-aided drug design (CADD) market is primarily driven by the increasing need for developing new drugs. The growing new drug discovery research and technological advancements drive the market. North America led the global market owing to the presence of key players and increasing investments....
April 21, 2026
Market insights predict the global cellular reprogramming tools industry will increase from USD 456.1 million in 2024 to USD 760.1 million by 2034, achieving a CAGR of 5.24%. The market is growing due to rising demand for regenerative medicine and personalized therapies. Advancements in gene editing and cell reprogramming technologies are further a...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries....
April 21, 2026
The pharmacovigilance automation market is growing due to it enhance the precision and effectiveness of drug safety monitoring by tracking and dealing with a huge amount of data. North America is dominant in the market due to stringent regulations and the presence of a large pharmaceutical sector....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
